A quality-by-design approach that defines potential viral contaminants of source materials can be used to achieve viral clearance.
Kathryn Martin Remington
Advertisement
Kathryn Martin Remington, PhD, is a principal scientist, development services with BioReliance by SAFC, Rockville, MD.
Articles by Kathryn Martin Remington
Advertisement
Latest Updated Articles
Application of Quality by Design to Viral SafetyOctober 1st 2014
Advertisement
Advertisement
Trending on BioPharm International
1
Sanofi Begins Construction of EU-Backed Insulin Plant in Frankfurt
2
Nano24's Inhaled EXO-CD24 Cuts ARDS Mortality in Phase 2b Trial
3
TaiMed’s Anti-CD4 Antibody TMB-365 Reduces HIV Viral Load in Phase 1, Supporting Long-Acting Combination Regimens
4
Akeso's Ivonescimab Enters Phase 2/3 Biliary Tract Cancer Trial in US
5